Image of Maha Reda Farhat

Maha Reda Farhat, M.D., M.D.,C.M.

617-432-4598

Maha Farhat  holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health. She is also a practicing physician at the Massachusetts General Hospital Division of Pulmonary and Critical Care Medicine.

Program in Global Surgery and Social Change

Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. To date, Farhat's work has focused on the pathogen Mycobacterium tuberculosis and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.


DBMI Research Areas
DBMI Courses
Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis.
Authors: Authors: Pollock N, Dhiman R, Daifalla N, Farhat M, Campos-Neto A.
Microbes Infect
View full abstract on Pubmed
Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
Authors: Authors: Farhat MR, Jacobson KR, Franke MF, Kaur D, Murray M, Mitnick CD.
Clin Infect Dis
View full abstract on Pubmed
Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
Authors: Authors: Nebenzahl-Guimaraes H, van Laarhoven A, Farhat MR, Koeken VACM, Mandemakers JJ, Zomer A, van Hijum SAFT, Netea MG, Murray M, van Crevel R, van Soolingen D.
Am J Respir Crit Care Med
View full abstract on Pubmed
Phenotypic and molecular study of pneumococci causing respiratory tract infections. A 3-year prospective cohort.
Authors: Authors: Alnimr AM, Farhat M.
Saudi Med J
View full abstract on Pubmed
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.
Authors: Authors: Farhat MR, Sultana R, Iartchouk O, Bozeman S, Galagan J, Sisk P, Stolte C, Nebenzahl-Guimaraes H, Jacobson K, Sloutsky A, Kaur D, Posey J, Kreiswirth BN, Kurepina N, Rigouts L, Streicher EM, Victor TC, Warren RM, van Soolingen D, Murray M.
Am J Respir Crit Care Med
View full abstract on Pubmed
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
Authors: Authors: Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong BC, Cambau E, Churchyard G, Cohen T, Delmee M, Delvenne JC, Farhat M, Habib A, Holme P, Keshavjee S, Khan A, Lightfoot P, Moore D, Moreno Y, Mundade Y, Pai M, Patel S, Nyaruhirira AU, Rocha LE, Takle J, Trébucq A, Creswell J, Boehme C.
Int J Tuberc Lung Dis
View full abstract on Pubmed
The nature, patterns, clinical outcomes, and financial impact of intraoperative adverse events in emergency surgery.
Authors: Authors: Ramly EP, Bohnen JD, Farhat MR, Razmdjou S, Mavros MN, Yeh DD, Lee J, Butler K, De Moya M, Velmahos GC, Kaafarani HM.
Am J Surg
View full abstract on Pubmed
Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
Authors: Authors: Farhat MR, Jacobson KR, Franke MF, Kaur D, Sloutsky A, Mitnick CD, Murray M.
J Clin Microbiol
View full abstract on Pubmed
Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
Authors: Authors: Farhat MR, Mitnick CD, Franke MF, Kaur D, Sloutsky A, Murray M, Jacobson KR.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
Authors: Authors: Nebenzahl-Guimaraes H, Jacobson KR, Farhat MR, Murray MB.
J Antimicrob Chemother
View full abstract on Pubmed